About the Speaker
  • Profession
    Head of Safety, Biosimilars
  • Company
    Fresenius Kabi SwissBioSim GmbH
  • Web Sites

Uwe Gudat, Head of Safety, Biosimilars at Fresenius Kabi SwissBioSim GmbH

Uwe Gudat received his medical degree from the University of Marburg, Germany. He is licensed in internal medicine and diabetology as a sub-speciality, training under Michael Berger in Düsseldorf Germany.

Uwe Gudat joined the pharmaceutical industry in 1995 with Eli Lilly and since then has held positions at Hesperion/Actelion, Novartis and Merck Serono. In this time he has led global clinical development teams, served as global medical brand director, led clinical teams for in-licensing due-diligence and managed clinical-trial review, first in man transitions and product safety assessments. Currently he is Head of Safety of the Merck Serono Biosimilars Unit.

He has published a number of scientific papers in the field of diabetes and is currently on the editorial advisory board of Applied Clinical Trials.